Is the VC Model Falling? PANEL SESSION

Andrew has spent the last ten years working in the pharmaceutical and biotechnology industries in the UK and has extensive experience in most aspects of these businesses, including compliance, manufacturing, research and development and licensing.  He spent from 2002 to 2006 as a Board Director of AIM listed company Allergy Therapeutics plc which he helped to take to market.